Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease. (Q45963204)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease. |
scientific article |
Statements
1 reference
Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease. (English)
1 reference
James M Olcese
1 reference
Chuanhai Cao
1 reference
Takashi Mori
1 reference
Malgorzata B Mamcarz
1 reference
Anne Maxwell
1 reference
Melissa J Runfeldt
1 reference
Li Wang
1 reference
Chi Zhang
1 reference
Xiaoyang Lin
1 reference
Guixin Zhang
1 reference
Gary W Arendash
1 reference
17 June 2009
1 reference
1 reference
47
1 reference
82-96
1 reference
1
1 reference
Identifiers
1 reference
1 reference